Início › Câncer de Próstata › Carolina do Sul › Charleston
Ensaios clínicos de Câncer de Próstata em Charleston, SC
15 estudos para Câncer de Próstata estão buscando participantes em locais em Charleston e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
RecrutandoFase 2
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecrutandoFase 2
- Medical University of South Carolina, Charleston
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RecrutandoFase 3
- Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083), Charleston
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RecrutandoFase 3
- MUSC Hollings Cancer Center, Charleston
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
RecrutandoFase 2
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
RecrutandoFase 1
- Medical University of South Carolina - Hollings Cancer Center, Charleston
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RecrutandoFase 3
- Medical University of South Carolina, Charleston
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RecrutandoFase 1
- Medical University of South Carolina, Charleston
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecrutandoFase 3
- Medical University of South Carolina, Charleston
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
RecrutandoEstudo observacional
- Ralph H. Johnson VA Medical Center, Charleston
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
RecrutandoFase 2
- Hollings Cancer Center at Medical University of South Carolina, Charleston
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
RecrutandoFase 2
- Medical University of South Carolina Hollings Cancer Center, Charleston
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Medical University of South Carolina, Charleston
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RecrutandoFase 1/2
- Research Site 123, Charleston
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecrutandoFase 3
- Medical University of South Carolina, Charleston
Ensaios de Câncer de Próstata em outras cidades
- New York City, NY103 estudos
- Houston, TX76 estudos
- Los Angeles, CA61 estudos
- Boston, MA59 estudos
- St. Louis, MO46 estudos
- Chicago, IL45 estudos
- San Francisco, CA45 estudos
- Philadelphia, PA44 estudos
- Baltimore, MD43 estudos
- Nashville, TN43 estudos
- Seattle, WA42 estudos
- Washington, DC38 estudos
Outros estudos em Charleston
- Depressão19 estudos
- Acidente Vascular Cerebral18 estudos
- Insuficiência Cardíaca18 estudos
- Câncer de Pulmão de Não Pequenas Células16 estudos
- Transtorno de Estresse Pós-Traumático16 estudos
- Doença Cardiovascular15 estudos
- Câncer (todos os tipos)14 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço14 estudos
- Doença de Parkinson13 estudos
- Doenças Pulmonares Intersticiais13 estudos
- Câncer de Mama12 estudos
- Câncer de Pulmão11 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.